| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Chloroxylenol adverse reaction (disorder) |
Causative agent (attribute) |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to chloroxylenol |
Causative agent (attribute) |
False |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chloroxylenol + hydrocortisone + pramoxine hydrochloride 1mg/10mg/10mg drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chloroxylenol + hydrocortisone + pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing camphor and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing aldioxa and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing benzocaine and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing chloroxylenol in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chloroxylenol in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to chloroxylenol |
Causative agent (attribute) |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
Has basis of strength substance (attribute) |
False |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
Has precise active ingredient |
False |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chloroxylenol in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing benzocaine and chloroxylenol in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only aldioxa and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only benzocaine and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only camphor and chloroxylenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Chloroxylenol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Benzocaine and chloroxylenol only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only chloroxylenol in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only chloroxylenol in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) |
Has precise active ingredient |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely chloroxylenol 48 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has precise active ingredient |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely chloroxylenol 48 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Chloroxylenol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]